Biotech · Private company
Tourmaline Bio, Inc., a Novartis Company
Track this companyFree. Adds Tourmaline Bio, Inc., a Novartis Company to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- TOUR006 - 15 MGPhase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- TOUR006 - 20 MGPhase 2 · Thyroid Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- TOUR006 - 25 MGPhase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- TOUR006 - 50 MGPhase 2 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- TOUR006 - 50 MGPhase 2 · Thyroid Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRPPHASE2 · COMPLETED · started May 15, 2024ClinicalTrials.gov NCT06362759 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Feb 19, 2024ClinicalTrials.gov NCT06088979 · fetched Nov 12, 2026